Effect of a single cyclosporine A (NEORAL™) dose on the single-dose pharmacokinetics (PK) of sitagliptin (MK-0431), a dipeptidyl peptidase-IV inhibitor (DPP-IV), in healthy male subjects.

被引：1

作者：

Krishna, R ^{[1
]}

Bergman, AJ ^{[1
]}

Larson, P ^{[1
]}

Cote, J ^{[1
]}

Lasseter, KC ^{[1
]}

Pierre, M ^{[1
]}

Wang, AQ ^{[1
]}

Zeng, W ^{[1
]}

Chen, L ^{[1
]}

Wagner, JA ^{[1
]}

Herman, GA ^{[1
]}

机构：

[1] Merck & Co Inc, Rahway, NJ 07065 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期

关键词：

D O I：

10.1016/j.clpt.2005.12.225

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：P63 / P63

页数：1

共 50 条

[31] Tolerability and single dose pharmacokinetics of a new PDE5 inhibitor, DA-8159 in healthy male subjects.
Hong, K
Lim, H
Cho, J
Chung, J
Oh, D
Yi, S
Bae, K
Jang, I
Baik, J
Shin, S
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P20 - P20
[32] Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
Herman, GA
Stevens, C
Van Dyck, K
Bergman, A
Yi, BM
De Smet, M
Snyder, E
Hilliard, D
Tanen, M
Tanaka, W
Wang, AQ
Zeng, W
Musson, D
Winchell, G
Davies, MJ
Ramael, S
Gottesdiener, KM
Wagner, JA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 675 - 688
[33] Pharmacokinetics and anticoagulant effect of BMS-189664 following single ascending oral and IV doses in healthy male subjects.
Hadjilambris, OW
Marino, MR
Langenbacher, KM
Ford, NF
Zielonka, J
Clementi, R
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 208 - 208
[34] Effects of Age, Gender and Obesity on the Single Dose Pharmacokinetics (PK) of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
Addy, Carol
Tatosian, Daniel
Hou, Xiaoli S.
Gendrano, Isaias N.
Martucci, Ashley
Wagner, John A.
Stoch, S. Aubrey
DIABETES, 2013, 62 : A301 - A301
[35] Single-dose pharmacokinetics of alogliptin benzoate (SYR-322), a highly selective dipeptidyl peptidase-4 inhibitor, in subjects with moderate hepatic impairment
Karim, A.
Fleck, P.
Dorsey, D.
Zhang, W.
Mekki, Q.
Preston, R. A.
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1207 - 1207
[36] Effects of Food Intake on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of the Dipeptidyl Peptidase 1 (DPP1) Inhibitor Brensocatib in Healthy Japanese and White Adults
Usansky, H.
Yoon, E.
Teper, A.
Fernandez, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[37] EFFECT OF MULTIPLE-DOSE SETIPIPRANT, A SELECTIVE ORAL CRTH2 ANTAGONIST, ON THE PHARMACOKINETICS OF SINGLE-DOSE SIMVASTATIN IN HEALTHY MALE SUBJECTS
Gehin, M.
Mackie, A.
Sidharta, P. N.
Kadlecova, P.
Petersen-Sylla, M.
Halabi, A.
Dingemanse, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S42 - S42
[38] Pharmacokinetics, Pharmacodynamics, and Tolerability of the Dipeptidyl Peptidase IV Inhibitor LC15-0444 in Healthy Korean Men: A Dose-Block-Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose, Phase I Study
Lim, Kyoung Soo
Kim, Jung-Ryul
Choi, Yun-Jung
Shin, Kwang-Hee
Kim, Kyu-Pyo
Hong, Jang-Hee
Cho, Joo-Youn
Shin, Hyun-Suk
Yu, Kyung-Sang
Shin, Sang-Goo
Kwon, O. Hwan
Hwang, Dal-Mi
Kim, Jeong-Ae
Jang, In-Jin
CLINICAL THERAPEUTICS, 2008, 30 (10) : 1817 - 1830
[39] A single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics (PK) of ceftaroline fosamil plus avibactam (CXL) administered by intravenous (IV) infusion to healthy subjects.
Riccobene, Todd
Su, Sheng Fang
Rank, Douglas R.
PHARMACOTHERAPY, 2012, 32 (10): : E212 - E212
[40] Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects
Johansson, S.
Cullberg, M.
Eriksson, U. G.
Elg, M.
Duner, K.
Jensen, E.
Wollbratt, M.
Wahlander, K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (04) : 258 - 267

← 1 2 3 4 5 →